GLP-1 peptide claims on TikTok: what the science actually shows

What did @teekaxoxo actually say?

Honestly? Nothing about GLP-1s. The transcript is entirely a person reacting to what appears to be a snake, possibly with a flashlight involved. Phrases like "the eye on the bottom of the snake" and "I gotta take this outside" dominate the clip. There is no medical claim here.

The video is hashtagged with #glp1, #glp1girlies, #biohacking, and #peptide, but the spoken content has zero overlap with any of those topics. This is a common TikTok tactic: attach high-traffic health hashtags to unrelated content to pull views from an audience actively searching for GLP-1 information. The creator says things like "wait, Tooty" and "you gotta do a sneak," none of which constitutes health guidance, a product recommendation, or even a vague wellness tip.

To be clear, this fact-check cannot assess what the creator intended to communicate about GLP-1 medications because they did not communicate anything about GLP-1 medications.

Does the science back this up?

There is no claim in this video to evaluate against the science. The transcript contains no assertions about semaglutide, tirzepatide, liraglutide, weight loss, blood sugar, appetite suppression, or any related mechanism. Fact-checking a snake sighting against clinical literature is not something we can do with a straight face.

That said, the hashtag context is worth addressing. GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have a substantial evidence base. The SUSTAIN and STEP trial series demonstrated meaningful reductions in HbA1c and body weight respectively (Marso et al., 2016, New England Journal of Medicine; Wilding et al., 2021, New England Journal of Medicine). These are legitimate, heavily studied drug classes. The problem is that no part of this video touches any of that. The hashtags are doing work the spoken content is not doing.

What did they get wrong (or right)?

There is nothing medically right or wrong in the transcript, because there is no medical content. What is worth flagging is the hashtag strategy itself. Tagging unrelated content with #glp1 and #peptide pulls viewers who may be genuinely looking for information about their medication or treatment options. Those viewers land on a video about a snake and get nothing useful.

This is not a small issue in the GLP-1 content space. A 2023 analysis of health misinformation on short-form video platforms (Loeb et al., 2023, European Urology) found that misleading or irrelevant health content frequently travels under legitimate medical hashtags, diluting the quality of information available to patients. The creator may not have intended harm, but the effect is the same: someone searching for GLP-1 guidance watches a clip about a flashlight and a reptile.

What should you actually know?

If you found this video by searching GLP-1 content, here is what is actually relevant to you. GLP-1 receptor agonists are prescription medications. They work by mimicking the glucagon-like peptide-1 hormone, slowing gastric emptying, reducing appetite, and stimulating insulin secretion in a glucose-dependent way. They are not peptide supplements you can stack casually.

Compounded versions of semaglutide are not equivalent to FDA-approved branded formulations. The FDA has been explicit about this. Dosing, purity, and sterility standards differ, and the agency issued warnings about compounded semaglutide products in 2023 and 2024. If you are considering a GLP-1 medication, that conversation belongs with a licensed clinician who has access to your health history, not a TikTok comment section or a hashtag feed that includes snake videos.

• GLP-1 medications require a prescription and medical supervision.
• Compounded GLP-1 products carry distinct regulatory and safety considerations from brand-name drugs.
• TikTok hashtags are not a reliable filter for accurate health information.
• If you have questions about whether a GLP-1 medication is appropriate for you, a regulated telehealth provider can give you a real clinical assessment.